Title | Type | SJR | H index | Total Docs. (2013) | Total Docs. (3years) | Total Refs. (2013) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2013) | %Female (2013) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Inflammopharmacology | journal | 0.795 Q2 | 68 | 41 | 102 | 2796 | 288 | 96 | 3.33 | 68.20 | 34.45 | |
52 | Expert Opinion on Pharmacotherapy | journal | 0.793 Q2 | 93 | 240 | 792 | 15993 | 2113 | 752 | 2.72 | 66.64 | 35.28 | |
53 | Cardiology | journal | 0.792 Q2 | 72 | 162 | 412 | 3944 | 662 | 295 | 1.59 | 24.35 | 27.48 | |
54 | European Journal of Contraception and Reproductive Health Care | journal | 0.769 Q2 | 53 | 63 | 185 | 1713 | 351 | 158 | 2.20 | 27.19 | 52.42 | |
55 | Photodiagnosis and Photodynamic Therapy | journal | 0.769 Q2 | 67 | 92 | 138 | 3150 | 357 | 127 | 2.51 | 34.24 | 35.89 | |
56 | Chemotherapy | journal | 0.767 Q2 | 61 | 46 | 188 | 1318 | 384 | 182 | 1.96 | 28.65 | 32.81 | |
57 | Pharmacopsychiatry | journal | 0.750 Q2 | 84 | 55 | 202 | 1841 | 430 | 174 | 2.51 | 33.47 | 33.06 | |
58 | Expert Review of Pharmacoeconomics and Outcomes Research | journal | 0.734 Q2 | 61 | 81 | 243 | 2971 | 564 | 217 | 2.35 | 36.68 | 37.06 | |
59 | Biopharmaceutics and Drug Disposition | journal | 0.729 Q2 | 65 | 47 | 144 | 1892 | 421 | 140 | 2.73 | 40.26 | 32.47 | |
60 | Expert Review of Clinical Pharmacology | journal | 0.706 Q2 | 60 | 70 | 216 | 3929 | 444 | 186 | 2.32 | 56.13 | 29.03 | |
61 | Therapeutic Advances in Cardiovascular Disease | journal | 0.694 Q2 | 41 | 30 | 80 | 1392 | 170 | 71 | 2.28 | 46.40 | 36.56 | |
62 | Fundamental and Clinical Pharmacology | journal | 0.687 Q2 | 85 | 75 | 253 | 3498 | 546 | 250 | 1.92 | 46.64 | 41.82 | |
63 | Paediatric Drugs | journal | 0.682 Q2 | 70 | 48 | 125 | 3587 | 280 | 118 | 2.09 | 74.73 | 48.91 | |
64 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.681 Q2 | 81 | 97 | 303 | 2609 | 726 | 296 | 2.15 | 26.90 | 31.92 | |
65 | Clinical Drug Investigation | journal | 0.646 Q2 | 67 | 150 | 274 | 3526 | 628 | 260 | 2.17 | 23.51 | 38.90 | |
66 | BMC Clinical Pharmacology | journal | 0.644 Q2 | 43 | 0 | 53 | 0 | 146 | 53 | 2.59 | 0.00 | 0.00 | |
67 | Journal of Infection and Chemotherapy | journal | 0.637 Q2 | 72 | 194 | 428 | 4579 | 673 | 416 | 1.45 | 23.60 | 20.69 | |
68 | International Journal of STD and AIDS | journal | 0.628 Q2 | 78 | 182 | 708 | 4137 | 827 | 634 | 1.11 | 22.73 | 44.85 | |
69 | Drug Target Insights | journal | 0.614 Q2 | 16 | 6 | 6 | 212 | 11 | 6 | 1.83 | 35.33 | 44.44 | |
70 | Antimicrobial Resistance and Infection Control | journal | 0.601 Q2 | 66 | 34 | 30 | 790 | 72 | 24 | 2.40 | 23.24 | 40.40 | |
71 | International Journal of Clinical Pharmacy | journal | 0.541 Q2 | 71 | 147 | 340 | 3828 | 562 | 322 | 1.48 | 26.04 | 49.32 | |
72 | Recent Patents on Anti-Infective Drug Discovery | journal | 0.444 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
73 | International Journal of Clinical Pharmacology and Therapeutics | journal | 0.432 Q2 | 73 | 138 | 395 | 2873 | 524 | 370 | 1.31 | 20.82 | 37.08 | |
74 | Drugs of Today | journal | 0.411 Q2 | 57 | 69 | 239 | 2615 | 336 | 236 | 1.57 | 37.90 | 29.55 | |
75 | Therapeutic Advances in Drug Safety | journal | 0.399 Q2 | 46 | 23 | 54 | 1033 | 42 | 48 | 0.85 | 44.91 | 32.43 | |
76 | European Review for Medical and Pharmacological Sciences | journal | 0.392 Q2 | 88 | 541 | 765 | 13851 | 1043 | 736 | 1.24 | 25.60 | 33.03 | |
77 | Drug Metabolism and Personalized Therapy | journal | 0.390 Q2 | 38 | 31 | 65 | 1189 | 103 | 58 | 1.56 | 38.35 | 41.13 | |
78 | European Journal of Drug Metabolism and Pharmacokinetics | journal | 0.389 Q2 | 47 | 35 | 90 | 975 | 129 | 90 | 1.58 | 27.86 | 40.72 | |
79 | Journal of Oncology Pharmacy Practice | journal | 0.384 Q3 | 44 | 61 | 176 | 1297 | 223 | 167 | 1.27 | 21.26 | 44.49 | |
80 | HIV Therapy | journal | 0.359 Q3 | 14 | 0 | 48 | 0 | 32 | 37 | 0.00 | 0.00 | 0.00 | |
81 | Recent Patents on Cardiovascular Drug Discovery | journal | 0.350 Q3 | 30 | 24 | 80 | 1551 | 103 | 77 | 1.55 | 64.63 | 32.98 | |
82 | Journal of Chemotherapy | journal | 0.347 Q3 | 56 | 53 | 241 | 1935 | 246 | 205 | 1.06 | 36.51 | 40.87 | |
83 | Journal of International Peacekeeping | journal | 0.333 Q3 | 14 | 17 | 50 | 1160 | 28 | 49 | 0.69 | 68.24 | 29.41 | |
84 | MeReC Bulletin | journal | 0.317 Q3 | 7 | 0 | 7 | 0 | 4 | 3 | 0.17 | 0.00 | 0.00 | |
85 | BMC pharmacology & toxicology | journal | 0.312 Q3 | 43 | 62 | 21 | 1946 | 17 | 18 | 0.81 | 31.39 | 36.66 | |
86 | Open Toxinology Journal | journal | 0.306 Q3 | 2 | 1 | 1 | 55 | 2 | 1 | 2.00 | 55.00 | 50.00 | |
87 | Pharmaceutical Medicine | journal | 0.263 Q3 | 25 | 16 | 82 | 651 | 70 | 64 | 0.93 | 40.69 | 35.00 | |
88 | Methods and Findings in Experimental and Clinical Pharmacology | journal | 0.239 Q3 | 56 | 0 | 86 | 0 | 72 | 77 | 0.00 | 0.00 | 0.00 | |
89 | Drugs of the Future | journal | 0.205 Q3 | 46 | 113 | 332 | 3797 | 160 | 330 | 0.36 | 33.60 | 33.33 | |
90 | Therapies | journal | 0.188 Q3 | 41 | 66 | 232 | 1264 | 92 | 193 | 0.39 | 19.15 | 51.38 | |
91 | Actualites Pharmaceutiques | journal | 0.187 Q3 | 6 | 170 | 573 | 703 | 7 | 520 | 0.01 | 4.14 | 60.49 | |
92 | Prescrire International | journal | 0.179 Q3 | 14 | 218 | 593 | 1038 | 108 | 545 | 0.20 | 4.76 | 42.86 | |
93 | Antibiotics | journal | 0.176 Q3 | 77 | 32 | 6 | 2220 | 3 | 5 | 0.60 | 69.38 | 41.79 | |
94 | Pharmacien Hospitalier et Clinicien | journal | 0.176 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
95 | Drug and Therapeutics Bulletin | journal | 0.169 Q3 | 17 | 142 | 324 | 945 | 59 | 106 | 0.13 | 6.65 | 0.00 | |
96 | International Arabic Journal of Antimicrobial Agents (discontinued) | journal | 0.165 Q3 | 9 | 16 | 24 | 461 | 10 | 23 | 0.42 | 28.81 | 42.55 | |
97 | Therapy | journal | 0.164 Q3 | 22 | 0 | 152 | 0 | 45 | 123 | 0.26 | 0.00 | 0.00 | |
98 | Open Neuropsychopharmacology Journal | journal | 0.163 Q3 | 6 | 0 | 11 | 0 | 3 | 11 | 0.10 | 0.00 | 0.00 | |
99 | Psychopharmakotherapie | journal | 0.157 Q3 | 13 | 80 | 266 | 1000 | 29 | 117 | 0.15 | 12.50 | 22.22 | |
100 | Farmaceutico Hospitales | journal | 0.155 Q3 | 3 | 0 | 35 | 0 | 3 | 22 | 0.14 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®